Aspirin ameliorates lung cancer by targeting the miR‐98/WNT1 axis

Aspirin ameliorates lung cancer by targeting the miR‐98/WNT1 axis

Background Aspirin, an anti‐inflammatory drug, has been widely investigated in the treatment of many cancer types, including colorectal, ovarian, breast, and prostate cancers. MicroRNAs (miRNAs) are the most well studied noncoding RNAs in cancers. In the current study, we were interested in defining...

Full description

Bibliographic Details
Main Authors: Huizhu Gan, Lin Lin, Nanjun Hu, Yang Yang, Yu Gao, Yu Pei, Kang Chen, Butong Sun
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Thoracic Cancer
Subjects:
Aspirin
cell proliferation
lung cancer
miR‐98
WNT1
Online Access:https://doi.org/10.1111/1759-7714.12992

Similar Items

Similar Items